By introducing an alternative to Epipen, CVS has brought sanity, compassion, and ultimately good business sense to this controversy. It is putting its customers first, but is also thinking about its long-term relationship with them—as well as sensible profits.
from Forbes Real Time https://www.forbes.com/sites/petergeorgescu/2017/09/27/fair-prices-fair-play-and-profitable-brands/
via IFTTT
No comments:
Post a Comment